Trial
NCT04580277
Tofacitinib For Treatment Of Chronic Pouchitis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Cedars-Sinai Medical Center
Collaborators
—
Condition
Pouchitis
Intervention
Tofacitinib 10 mg
Why stopped
low recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-04